LRTM3 and renal cell carcinoma: CCDC168 is reported to have a frequent mutation in pediatric renal cell carcinomas (Beck et al. 2022), malignant pleural mesothelioma (Yu et al. 2021), and colon adenocarcinoma (Cortes-Ciriano et al. 2017).